40,000 Shares in BioVie Inc. (NASDAQ:BIVI) Bought by Sanders Morris Harris LLC

Sanders Morris Harris LLC acquired a new stake in shares of BioVie Inc. (NASDAQ:BIVI) during the fourth quarter, Holdings Channel reports. The fund acquired 40,000 shares of the company’s stock, valued at approximately $85,000.

BioVie Trading Down 0.5 %

BIVI stock traded down $0.01 during mid-day trading on Thursday, hitting $2.21. 31,592 shares of the company were exchanged, compared to its average volume of 1,172,469. The company has a market capitalization of $39.27 million, a PE ratio of -0.19 and a beta of 0.49. The firm has a fifty day simple moving average of $2.62 and a 200 day simple moving average of $2.09. BioVie Inc. has a twelve month low of $1.04 and a twelve month high of $33.10.

BioVie Company Profile

BioVie Inc, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease, as well as Phase 2 clinical trial for the treatment of Parkinson's disease.